Living well: Tackling iron deficiency in women and girls with a genetic bleeding disorder

About the author

Jessica looked at a campaign for The Haemophilia Society for her CIPR Professional PR Diploma Unit 1 assignment. It has been edited into case study format with a full list of references at the end.

Eighty percent of women and girls [1] with a genetic bleeding disorder experience heavy menstrual bleeding, commonly resulting in iron deficiency anaemia which can significantly disrupt their education, employment and social relationships. Women and girls’ quality of life is being compromised due an inconsistent approach to monitoring and addressing this easily treatable condition.

The Haemophilia Society (THS) wants to support women and girls in getting the best treatment and care available by advocating for universal testing and monitoring of iron levels at treatment centres.

Iron deficiency anaemia (IDA) causes fatigue and headaches and, if left untreated, can increase the risk of illness and infection as lack of iron affects the immune system[2]. Treatment is in the form of inexpensive oral or intravenous iron supplements.

Some 18,000 women with a diagnosed bleeding disorder are at risk of being iron deficient. While some are monitored and treated effectively, others are not receiving optimal care, potentially resulting in poor health and missed days at work or school. The most recent research suggests highly variable clinical practice, with between one quarter and 100% of women and girls with a bleeding disorder and heavy menstrual bleeding (HMB) having their iron levels checked[3], depending on their treatment centre.

Ongoing stigma surrounding menstrual bleeding and misconceptions about what constitutes ‘normal’ bleeding also hamper clinical discussion[4,5].

So, how can the Haemophilia Society’s (THS) communications strategy help to get bleeding disorder treatment centres to improve their monitoring and treatment of iron deficiency in women and girls?

Improving clinical practice and the quality of life of those affected will help to position THS as an effective patient advocate and strengthen trust with its supporter base. Action will satisfy corporate sponsors and encourage them to fund future projects. Supporters may be empowered to improve their own care, improving perceptions of THS’s relevance to their lives.

About the Haemophilia Society

THS is a charity for everyone in the UK with a genetic bleeding disorder. It advocates for safe and effective treatment and brings together people with a bleeding disorder and their families to share experiences and create support networks.

The charity has 5,500 members, 56% of whom are female. Of that number, 847 women and girls have a diagnosed bleeding disorder and the rest identify themselves as carers or family members of someone with a bleeding disorder[6].

There are 23,332 women and girls with diagnosed bleeding disorders in the UK, more than half (54%) of all registered patients on the UK National Haemophilia Database[7].

About 80% of women and girls with a diagnosed genetic bleeding disorder experience HMB. Extremely heavy periods can result in missed working days and disrupted education as well as feeling fatigued and unwell, which is often linked to iron depletion. It is estimated that the impact of absenteeism annually in the UK from heavy periods is £4.7 billion[8].

Developing the strategy

To identify the best strategy, THS must first understand current practice regarding the monitoring and treatment of women and girls with a genetic bleeding disorder.

A recent UK haemophilia doctors’ survey of haemophilia treatment centres of the current gynaecological management of women and girls with bleeding disorders in the UK found an ‘urgent need for routine clinical practices around detection and monitoring of iron deficiency to change’[9]. The authors conclude that ‘clinical practices for checking iron status were highly variable’ and recommended ‘universal, routine testing of iron status’ as an area for immediate prioritisation.

An additional factor in addressing iron deficiency, as well as other HMB-related issues, is the stigma and shame some women and girls feel in discussing their periods[10]. Also, because of the genetic nature of bleeding disorders, some women do not know what a ‘normal’ period looks like because the other females in their family bleed the same way[11].

Barriers to optimal care for women and girls

A report by THS in 2025 concluded: ‘Bleeding disorder care has struggled to break out of a financial and clinical mindset that often sees women and girls as secondary patients to men and boys with haemophilia’[12]. On average, women are diagnosed with a bleeding disorder 16 years later than men and it’s estimated that that up to 50,000 could live with an undiagnosed bleeding disorder, in part because common symptoms such as HMB are not investigated[13].

Bleeding disorder care has historically focused on the most severely affected patients which, in some but not all genetic bleeding disorders, is men. For example, men are overwhelmingly more likely to have the most severe forms of haemophilia, which is passed on genetically through females. There are 2,386 men registered in the UK with severe haemophilia A and only 18 women[14]. However, of the 9,999 total number of haemophilia diagnoses, women account for 3,044, of whom 40% are likely to experience HMB[15].

A THS report, based on conversations with more than 100 women and girls, highlights that women’s needs are different and that they need to be treated differently[16]. The UKHCDO recommends that the ‘physical and psychological impact of HMB on women’s lives is evaluated at every assessment, and this should include evaluation of iron status and/or anaemia, assessment of HMB and other menstrual cycle symptoms, and the impact of HMB on a woman’s quality of life’[17]. Yet its survey of specialist treatment centres found that at least two routinely referred women back to their GP to deal with symptoms of HMB.[18]

Research suggests that despite a growing recognition of women’s bleeding disorders, specialist clinicians have been slow to adapt their care.

A survey of the views of 280 women with bleeding disorders found that participants who had seen a specialist rated their understanding of their condition as worse than those who had not.[19]

The genetic nature of bleeding disorders is both a support and a barrier. Family members – male and female – are more likely to understand the impact of bleeding and have a more general awareness about related conditions, such as iron deficiency. The negative impact is that there is often a ‘normalisation’ of bleeding symptoms, particularly in relation to periods which leads to late clinical recognition[20]. An additional impact is stigma associated with genetic bleeding disorders in some ethnic minority communities which can impair open discussion about symptoms.

As a charity reliant on donations, grants and legacies for survival, THS’s relationship with its stakeholders strives to build trust, demonstrate relevance and uphold its integrity with every interaction. THS knows the importance of maintaining and enhancing its reputation in their eyes but, as Griffin notes, is mindful that this comes from ‘a promise delivered, not made’.[21]

The power/interest matrix is a good starting point, although more nuanced segmentation is needed.

Low interest High interest
Low power Minimal effort

  • GPs
  • Parents of newly diagnosed children with bleeding disorders
Keep informed

  • Relatives of women and girls with bleeding disorders
  • Men with bleeding disorders (may have genetic link to women affected)
  • Women with heavy menstrual bleeding
  • THS Young Ambassadors
High power Keep satisfied

  • NICE
  • Clinical Reference Group: Specialised blood disorders
  • Royal College of Obstetrics and Gynaecology
  • All Party Parliamentary Group on Haemophilia and Contaminated Blood
  • Corporate partners
  • European Haemophilia Consortium
  • World Federation of Haemophilia
Key players

  • Trustees
  • Women and girls with bleeding disorders
  • Bleeding disorder clinicians
  • UKHCDO
  • Haemophilia Nurses Association
  • THS’s von Willebrand Disorder Working Group
  • THS’s Women’s Working Group
  • THS Patrons

While socio-economic and geodemographic factors are useful in understanding stakeholders’ access to healthcare, mapping stakeholders for this project is usefully informed by Grunig and Hunt’s ‘situational theory’ of publics[22]. Highlighting the need for detection and treatment of iron deficiency will result in ‘problem recognition’ (women who recognise the symptoms, or a carer or family member of someone who has those symptoms) and their level of involvement will be enhanced by their connection to this issue. As people who already live with a rare condition, they are information seekers – well versed in finding out about their disorder in the face of limited recognition – and are likely to be ‘active publics’.

THS research has shown that a barrier to optimal treatment is the stigma and shame attached to discussion of menstruation. Understanding the way people ‘think, feel and behave’[23] is crucial in segmenting stakeholders. THS’s working groups offer useful insights of lived experience to inform the campaign and will support an ongoing evaluation of progress.

Yaxley[24] recommends using psychographics to segment stakeholders where a change in knowledge, attitude or awareness may be sought. In this case, we could potentially segment women and girls with bleeding disorders and HMB according to their lifestyles, with those active and sociable potentially most likely to feel held back by their condition and motivated to improve their treatment.

Campaign recommendation

A campaign to improve monitoring and treatment of iron deficiency for women and girls with a bleeding disorder provides an opportunity for THS to position itself as a leader in improving care for members. It offers a useful bridge to collaborate with haemophilia treatment centres and begin conversations about achieving other longer-term recommendations from its 2025 report into the treatment and care of women and girls.

In accordance with the Barcelona Principles[25], it is important for THS to use measurement and evaluation to engage in active and ongoing listening to stakeholders, as well as assessing outcomes and impact.

Key messages would focus on tailoring information to target audiences to increase understanding and facilitate action using the issues and motivations identified (improving health and quality of life/empowering patients/supporting existing clinical guidance/overcoming stigma/recognising symptoms and risks of IDA).

Campaign objectives

The following awareness and action objectives are proposed[26]:

  • Awareness objective: To increase women and girls with a bleeding disorders’ knowledge of the symptoms and impact of iron deficiency anaemia by 25% in the next 12 months.
  • Awareness objective: To increase understanding among women and girls with a bleeding disorder that heavy menstrual bleeding puts them at high risk of iron deficiency anaemia by 25% in the next 12 months.
  • Awareness objective: To increase awareness of women and girls with a bleeding disorder that they should be monitored and treated for iron deficiency by 25% in the next 12 months.
  • Action objective: To increase membership of THS among women and girls by 5% in the next 12 months.
  • Action objective: To achieve an average iron testing baseline on women with a genetic bleeding disorder and HMB of 75% across all UK haemophilia centres within 24 months.Proposed further task objectives:
    • To work with UKHCDO to establish agreed current baseline iron testing data to evaluate objectives.
    • To collaborate with the Haemophilia Nurses Association (HNA) to understand what role its members could play in supporting the objectives.
    • To collaborate with THS’s working groups on von Willebrand disorder and rare bleeding disorders to evaluate objectives.
    • To work with NICE on expanding its HMB treatment guidance to include women and girls with a genetic bleeding disorder.

PESTLE Analysis

Political Economic Social
Campaign picks up themes identified in the government’s Women’s Health Strategy for England (2022), such as more female-centred health research and the social and economic impact of living with HMB.

THS is currently bidding for funding from the Department of Health and Social Care (DHSC) related to other aspects of its work.

Charity resources to support this campaign are likely to be significant, mainly in terms of staff time. In addition to developing communication resources, success will involve other team members visiting haemophilia centres and consulting with working groups.

The campaign does not aim to raise money but increasing engagement and awareness of THS work could lead to an uptick in financial donations.

Momentum is building behind greater understanding of women’s health issues, including HMB, with more emphasis on listening and acting on female patients’ concerns.[27]

Three recent public inquiries into NHS maternity services[28], the safety of vaginal mesh[29] and issues arising following the conviction of breast surgeon Ian Paterson[30] all conclude that women’s voices were not listened to by NHS decision-makers and call for institutional change.

More women in the public eye are speaking about their periods, helping to reduce stigma and normalise clinical conversations about menstruation.[31]

Technological Legal Environmental
Growth of social media influence, allowing experiences to be heard and shared. Risk of trolling needs careful discussion with potential case studies.

New THS Customer Relationship Management (CRM) system collects more membership data and facilitates sophisticated segmenting for a more personalised communications approach.

Charities Act 2011 dictates how THS must operate. This campaign does not contravene any regulations. Not relevant

SWOT analysis

Stengths Weaknesses
Visible action on an issue identified as a priority by bleeding disorder clinicians.

The campaign is easy to understand and has simple, achievable goals.

Corporate sponsors of a related THS research project in 2025 will feel their financial support resulted in change which reflects positively on their organisations and cements their affiliation to THS.

Shows leadership and a willingness to initiate change.

Involves THS’s working groups, strengthening involvement and creating a sense of ownership.

Relevant across England, Scotland, Northern Ireland and Wales.

If successful, this is a would be a relatively small clinical change. Larger issues around lack of research and limited treatment options for women and girls remain. Without swift follow-up on more substantive areas of concern this could be seen as a token gesture.

THS membership is 44% male who may not relate to this campaign, although genetic nature of bleeding disorders means they may have familial link to a female affected.

Lack of historic data on women and girls with bleeding disorders makes it more difficult to create baseline measurements.

Opportunities Threats
Women and girls with bleeding disorders are a vocal and active group within THS. Engaging them will reinforce the charity’s relevance to their lives and strengthen support for future advocacy work.

Heavy menstrual bleeding is a ‘bridge’ issue which makes THS’s work more relatable to women outside the genetic bleeding disorders community. Particularly relevant to creating engaging, shareable social content.

Build more engagement with bleeding disorder clinicians. Campaign could be useful tool to visit more treatment centres and ensure a two-way conversation is in place.

Increase THS membership.

Risk that bleeding disorder clinicians will feel criticised and be defensive

On-going negotiations with DHSC on funding a separate area of THS work. No obvious reason for concern but should be considered.

Thank you Jessica for being willing to share an edited version of your CIPR Professional PR Diploma Unit 1 assignment on such an important topic.

What the assessors said about Jessica’s assignment:

…. your emphasis on partnership working and in addressing the stigma of heavy menstrual bleeding suggests the contribution that PR and comms can make to The Haemophilia Society. Your approach shows clear linkages between the research and the formulation of objectives, so it’s a strong response to the assignment brief……………. You understand your brief and write very precisely about the causes and effects of iron deficiency anaemia…….You make a coherent case to first address the stigma and then treat the symptoms – and in so doing you turn a clinical campaign into a comms campaign.

We hope Jessica’s work has inspired you to consider a CIPR qualification.  We’d love you to join hundreds of other PR and communication practitioners in studying for a CIPR qualification.

Check out our guide to CIPR qualifications